ArticleFrontiers in immunology2023
Immunogenicity and protective efficacy of an RSV G S177Q central conserved domain nanoparticle vaccine.
Harrison C Bergeron et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.
6 papers cite it
this papercites it